I wouldn't be surprised to see a 10:1 share reduction coming which will rerate the number of shares on offer, but will up the share price. This will allow more shares to be offered on NASDAQ at the higher rate. The problem I see is that being on NASDAQ, doesn't get any more Prizma's sold. Its not the ASX that is holding back sales.
Ann: G Medical seeks delisting to pursue Q4 NASDAQ listing, page-43
-
- There are more pages in this discussion • 645 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)